Delivery Order SPE2DB25D3017-SPE2DB25FVJNB
- Not listed
- The Defense Logistics Agency awarded a $22,664.40 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Humira (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of September 18, 2025. This contract utilizes firm fixed pricing and was competitively awarded with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,610.60 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $14,127.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of September 23, 2025. This is a non-set-aside contract issued to the Corporate Office division of the company, headquartered in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement under AmerisourceBergen's larger federal contract portfolio with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $14,646.25 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on June 10, 2025, with an ultimate completion date of June 11, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a competitive award to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,041.43 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical products. This is a firm fixed price, competitive delivery order with no set-aside designation, with an ultimate completion date of September 25, 2025. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $28,735.76 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on May 20, 2025, with completion scheduled for May 21, 2025. This is a firm fixed price contract with no set-aside designation, executed through competitive procedures. The award reflects a single-line delivery order for the pharmaceutical product to support federal medical procurement needs, with performance taking place at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $10,126.03 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on April 21, 2025, with an ultimate completion date of April 22, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger indefinite delivery contract vehicle that enables AmerisourceBergen to supply pharmaceutical...
- The Defense Logistics Agency awarded a $8,170 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on April 21, 2025, with an ultimate completion date of April 22, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical product will be performed at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this contract. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $43,110.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with final delivery required by July 15, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is issued...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVJNBDelivery Order
The Defense Logistics Agency awarded a $32,686.99 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on June 20, 2025, with an ultimate completion date of June 23, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. Through this contract vehicle, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.7k | 6/20/25 |